The diagnosis of coccidioidomycosis

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Until recently, culture, microscopy, and serology have been the available methods for the diagnosis of coccidioidomycosis. While Coccidioides is frequently isolated by culture, special precautions must be taken because of the risk of laboratory infection and because Coccidioides is on the Select Agent list. Serology is useful but the sensitivity remains lower than desired. A commercially available test for coccidioidal galactomannan antigenuria now exists and appears useful for immunocompromised hosts with severe disease. Polymerase chain reaction assays targeting specific coccidioidal genes have demonstrated utility but are not commercially available. Moreover, their sensitivity and the best sample type remain unestablished.

Original languageEnglish (US)
Article number2
JournalF1000 Medicine Reports
Volume2
Issue number1
DOIs
StatePublished - Jan 18 2010
Externally publishedYes

Fingerprint

Coccidioides
Coccidioidomycosis
Serology
Laboratory Infection
Immunocompromised Host
Microscopy
Polymerase Chain Reaction
Genes
galactomannan

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The diagnosis of coccidioidomycosis. / Ampel, Neil M.

In: F1000 Medicine Reports, Vol. 2, No. 1, 2, 18.01.2010.

Research output: Contribution to journalArticle

@article{be65ca0fd4fb412ca7d5bb4f60691f07,
title = "The diagnosis of coccidioidomycosis",
abstract = "Until recently, culture, microscopy, and serology have been the available methods for the diagnosis of coccidioidomycosis. While Coccidioides is frequently isolated by culture, special precautions must be taken because of the risk of laboratory infection and because Coccidioides is on the Select Agent list. Serology is useful but the sensitivity remains lower than desired. A commercially available test for coccidioidal galactomannan antigenuria now exists and appears useful for immunocompromised hosts with severe disease. Polymerase chain reaction assays targeting specific coccidioidal genes have demonstrated utility but are not commercially available. Moreover, their sensitivity and the best sample type remain unestablished.",
author = "Ampel, {Neil M.}",
year = "2010",
month = "1",
day = "18",
doi = "10.3410/M2-2",
language = "English (US)",
volume = "2",
journal = "F1000 Medicine Reports",
issn = "1757-5931",
publisher = "Medicine Reports Limited",
number = "1",

}

TY - JOUR

T1 - The diagnosis of coccidioidomycosis

AU - Ampel, Neil M.

PY - 2010/1/18

Y1 - 2010/1/18

N2 - Until recently, culture, microscopy, and serology have been the available methods for the diagnosis of coccidioidomycosis. While Coccidioides is frequently isolated by culture, special precautions must be taken because of the risk of laboratory infection and because Coccidioides is on the Select Agent list. Serology is useful but the sensitivity remains lower than desired. A commercially available test for coccidioidal galactomannan antigenuria now exists and appears useful for immunocompromised hosts with severe disease. Polymerase chain reaction assays targeting specific coccidioidal genes have demonstrated utility but are not commercially available. Moreover, their sensitivity and the best sample type remain unestablished.

AB - Until recently, culture, microscopy, and serology have been the available methods for the diagnosis of coccidioidomycosis. While Coccidioides is frequently isolated by culture, special precautions must be taken because of the risk of laboratory infection and because Coccidioides is on the Select Agent list. Serology is useful but the sensitivity remains lower than desired. A commercially available test for coccidioidal galactomannan antigenuria now exists and appears useful for immunocompromised hosts with severe disease. Polymerase chain reaction assays targeting specific coccidioidal genes have demonstrated utility but are not commercially available. Moreover, their sensitivity and the best sample type remain unestablished.

UR - http://www.scopus.com/inward/record.url?scp=77955082092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955082092&partnerID=8YFLogxK

U2 - 10.3410/M2-2

DO - 10.3410/M2-2

M3 - Article

C2 - 20948866

AN - SCOPUS:77955082092

VL - 2

JO - F1000 Medicine Reports

JF - F1000 Medicine Reports

SN - 1757-5931

IS - 1

M1 - 2

ER -